Jim Cramer Explains How Market Rotation Boosted Companies Like Johnson & Johnson

Group 1 - Johnson & Johnson (NYSE: JNJ) has shown a 10% upside recently, attributed to a rotation of investment from high-flying tech stocks like Meta, Microsoft, and NVIDIA to more stable growth areas such as healthcare [1] - The company develops and sells a wide range of healthcare products, including pharmaceuticals and medical technologies, with a focus on immunology, oncology, neuroscience, cardiovascular care, and infectious diseases [2] - Johnson & Johnson also provides surgical systems, orthopedic solutions, cardiovascular devices, and vision care products, indicating a diverse product portfolio in the healthcare sector [2] Group 2 - While Johnson & Johnson is recognized for its potential as an investment, certain AI stocks are suggested to offer greater upside potential and lower downside risk, indicating a competitive investment landscape [3]